查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2076211

早產和胎膜早破 (PROM) 檢測市場：按產品類型、檢測類型、最終用戶和地區分類。

Preterm Birth and PROM Testing Market, By Product Type, By Test Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年，早產和胎膜早破 (PROM) 檢測市場規模將達到 20.4 億美元，到 2033 年將達到 31.8 億美元。預計 2026 年至 2033 年的複合年成長率將達到 6.5%。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 20.4億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 6.50% 2033年市場規模預測： 31.8億美元

早產是全球面臨的重大健康問題。它指的是妊娠不足37週的嬰兒出生。根據世界衛生組織（世衛組織）統計，每年約有1500萬個嬰兒早產，約佔全球出生總數的十分之一。早產會導致多種健康併發症，也是新生兒死亡和發病的主要原因之一。

羊膜破裂（PROM）檢測是評估早產風險的重要診斷工具。此檢測有助於在分娩開始前早期發現羊膜破裂。透過檢測羊水的存在，PROM檢測可以幫助醫護人員為有早產風險的孕婦提供更充分的管理和照護決策。

市場動態：

早產和胎膜早破檢測市場的主要驅動力是全球早產發生率的上升。孕婦年齡、多胎妊娠、產前保健不足、感染疾病以及社會經濟因素等都會導致早產率的增加。胎膜早破檢測在識別早產風險方面發揮至關重要的作用，使醫護人員能夠及時干預，改善新生兒預後。

然而，一些阻礙因素可能會阻礙市場成長。這些因素包括胎膜早破檢測套組高成本、開發中地區醫療設施匱乏，以及孕婦和醫護人員對早產和胎膜早破檢測缺乏了解。

另一方面，受患者報告結局測量（PROM）檢測方法的技術進步、即時檢測日益受到重視以及個性化醫療需求不斷成長的推動，市場蘊藏著巨大的機會。市場新進業者正加大研發投入，致力於開發創新PROM檢測套組，以提高檢測的準確性、易用性和成本效益。

總體而言，由於人們對早產的認知不斷提高、胎膜早破檢測方法不斷進步，以及早期發現和早期療育以改善新生兒預後的需求日益成長，早產和胎膜早破檢測市場正經歷顯著成長。市場參與者正在製定策略，以拓展產品系列、與關鍵相關人員合作，並挖掘尚未開發的市場潛力。

本研究的主要特點：

  • 這項研究揭示了各個細分市場的潛在成長機會，並為該市場說明了一個有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數，介紹了全球早產和胎膜早破檢測市場主要參與者的概況：公司概況、產品系列、主要亮點、財務績效和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球早產和胎膜早破檢測市場」報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球早產和胎膜早破檢測市場所使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 早產兒數量增加
    • 產前診斷測試費用高昂
    • 新興經濟體蘊藏著巨大的未開發潛力
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品類型上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章：早產及胎膜早破（PROM）檢測市場：依產品類型分類，2021-2033年

  • 試劑盒和試劑
  • 裝置
  • 消耗品

第5章：早產及胎膜早破（PROM）檢測市場：依檢測類型分類，2021-2033年

  • 骨盆腔檢查
  • 超音波檢查
  • 子宮監測
  • 生物標記檢測
  • 其他

第6章：早產和胎膜早破（PROM）檢測市場：依最終用戶分類，2021-2033年

  • 醫院
  • 診斷檢測實驗室
  • 門診部
  • 研究中心
  • 其他

第7章 早產和胎膜早破（PROM）檢測市場：按地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • Abbott Laboratories
  • Biosynex
  • Qiagen NV
  • Clinical Innovations, LLC
  • Sera Prognostics
  • Hologic, Inc.
  • IQ Products
  • NX Prenatal, Inc.
  • Promega Corporation
  • Insight Pharmaceuticals LLC
  • Creative Diagnostics

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6403

Preterm Birth and PROM Testing Market is estimated to be valued at USD 2.04 Bn in 2026 and is expected to reach USD 3.18 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.50% 2033 Value Projection: USD 3.18 Bn

Preterm birth, also known as premature birth, is a significant global health concern. It refers to the birth of a baby before 37 completed weeks of gestation. According to the World Health Organization (WHO), around 15 million babies are born prematurely each year, accounting for approximately one in 10 births worldwide. Preterm birth can lead to various health complications and is one of the leading causes of neonatal mortality and morbidity.

PROM testing, which stands for prelabor rupture of membranes, is an important diagnostic tool used to assess the risk of preterm birth. It helps in the early detection of membrane rupture before the onset of labor. By detecting the presence of amniotic fluid, PROM testing helps healthcare professionals make informed decisions regarding the management and care of pregnant women at risk of premature birth.

Market Dynamics:

The preterm birth and PROM testing market is primarily driven by the increasing incidence of preterm births worldwide. Factors, such as maternal age, multiple pregnancies, poor prenatal care, infections, and socioeconomic factors, contribute to the rise in preterm births. PROM testing plays a crucial role in identifying the risk of preterm birth, enabling healthcare professionals to provide timely interventions and improve neonatal outcomes.

However, there are certain restraints that can hinder the growth of the market. These include the high cost of PROM testing kits, limited access to healthcare facilities in developing regions, and the lack of awareness about preterm birth and PROM testing among pregnant women and healthcare providers.

On the other hand, there are significant opportunities in the market, driven by technological advancements in PROM testing methods, increasing focus on point-of-care testing, and the growing demand for personalized medicine. Market players are investing in research and development activities to develop innovative PROM testing kits with improved accuracy, ease of use, and cost-effectiveness.

Overall, the preterm birth and PROM testing market is witnessing substantial growth, driven by the increasing awareness about preterm birth, advancements in PROM testing methods, and the need for early detection and intervention to improve neonatal outcomes. Market players are strategizing to expand their product portfolios, collaborate with key stakeholders, and explore the untapped market potential.

Key Features of the Study:

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preterm birth and PROM testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, Hologic, Inc., IQ Products, NX Prenatal, Inc., PROMega Corporation, Insight Pharmaceuticals LLC, and Creative Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global preterm birth and PROM testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preterm birth and PROM testing market

Detailed Segmentation:

  • By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Kits and Reagents
  • Instruments
  • Consumables
  • By Test Type (Revenue, USD Bn, 2021 - 2033)
  • Pelvic exam
  • Ultrasound
  • Uterine monitoring
  • Biomarker testing
  • Others
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostics laboratories
  • Outpatient clinics
  • Research centers
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in the Preterm Birth and PROM Testing Market
  • Abbott Laboratories
  • Biosynex
  • Qiagen Sciences LLC
  • Clinical Innovations, LLC
  • Sera Prognostics
  • Hologic, Inc.
  • IQ Products
  • NX Prenatal, Inc.
  • Promega Corporation
  • Medical predictive Technologies Inc.
  • Creative Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Preterm Birth And PROM Testing Market, By Product Type
    • Preterm Birth And PROM Testing Market, By Test Type
    • Preterm Birth And PROM Testing Market, By End User
    • Preterm Birth And PROM Testing Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of preterm births
    • High costs of prenatal diagnostic tests
    • Significant untapped potential in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Preterm Birth and PROM Testing Market, By Product Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Kits and Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

5. Preterm Birth and PROM Testing Market, By Test Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pelvic exam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Ultrasound
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Uterine monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Biomarker testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Preterm Birth and PROM Testing Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Diagnostics laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Outpatient clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Research centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)

7. Preterm Birth and PROM Testing Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biosynex
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clinical Innovations, LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sera Prognostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IQ Products
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NX Prenatal, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Insight Pharmaceuticals LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Creative Diagnostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us